DH · NASDAQ
Definitive Healthcare (DH) Stock Price & Fundamentals
Definitive Healthcare (DH) closed at $448.14 on Oct 9, 2026, up 1.18% from the previous close of $442.93.
Share price, past year
1Y −5.03%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $448.14 |
| Sep 30, 2026 | $434.14 |
| Aug 31, 2026 | $442.46 |
| Jul 31, 2026 | $443.90 |
| Jun 30, 2026 | $435.09 |
| May 29, 2026 | $430.54 |
| Apr 30, 2026 | $448.97 |
| Mar 31, 2026 | $462.73 |
| Feb 27, 2026 | $471.26 |
| Jan 30, 2026 | $486.04 |
| Dec 31, 2025 | $508.54 |
| Nov 28, 2025 | $478.67 |
| Oct 31, 2025 | $473.75 |
Key statistics
- Market cap
- $47.84B
- P/E (TTM)
- —
- EPS (TTM)
- −$1.65
- Revenue (TTM)
- $232.70M
- Net income (TTM)
- −$168.20M
- Shares outstanding
- 106.7M
- Dividend yield
- —
- 52-week range
- $430.54 – $513.02
Definitive Healthcare's market cap is $47.84B, based on a share price of $448.14 and 106.7M shares outstanding as of Aug 6, 2026.
Financials
Definitive Healthcare reported revenue of $241.52M for fiscal 2025, down 4.24% from fiscal 2024.
Definitive Healthcare reported a net loss of $138.93M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $241.52M | −4.2% | −$138.93M | −57.5% | −$1.30 | $37.06M |
| FY2024ended Dec 31, 2024 | $252.20M | +0.3% | −$413.12M | −163.8% | −$3.54 | $45.85M |
| FY2023ended Dec 31, 2023 | $251.42M | +12.9% | −$202.39M | −80.5% | −$1.79 | $38.21M |
| FY2022ended Dec 31, 2022 | $222.65M | +34.0% | −$7.22M | −3.2% | −$0.07 | $27.25M |
| FY2021ended Dec 31, 2021 | $166.15M | +40.4% | −$17.84M | −10.7% | −$0.19 | $18.48M |
| FY2020ended Dec 31, 2020 | $118.32M | — | $0.00 | 0.0% | — | $21.82M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $55.20M | −$5.42M | −$0.05 |
| Q1 FY2026ended Mar 31, 2026 | $55.93M | −$138.62M | −$1.32 |
| Q4 FY2025ended Dec 31, 2025 | $61.53M | −$9.32M | −$0.14 |
| Q3 FY2025ended Sep 30, 2025 | $60.05M | −$14.84M | −$0.14 |
| Q2 FY2025ended Jun 30, 2025 | $60.75M | −$7.55M | −$0.07 |
| Q1 FY2025ended Mar 31, 2025 | $59.19M | −$107.23M | −$0.95 |
| Q4 FY2024ended Dec 31, 2024 | $62.29M | −$59.08M | −$0.53 |
| Q3 FY2024ended Sep 30, 2024 | $62.70M | −$130.90M | −$1.12 |
Company profile
- Name
- Definitive Healthcare Corp.
- Ticker
- DH
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Services-Prepackaged Software
- Headquarters
- 492 Old Connecticut Path, Suite 401, Framingham, MA 01701
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001861795
Recent SEC filings
- Sep 9, 2026
- Sep 2, 2026
- Sep 2, 2026
- Aug 10, 2026
- Aug 10, 2026
- Jun 24, 2026
- Jun 5, 2026
- May 7, 2026
Frequently asked questions
What is Definitive Healthcare's stock price?
Definitive Healthcare (DH) closed at $448.14 on Oct 9, 2026, up 1.18% from the previous close of $442.93.
What is Definitive Healthcare's market cap?
Definitive Healthcare's market cap is $47.84B, based on a share price of $448.14 and 106.7M shares outstanding as of Aug 6, 2026.
How much revenue does Definitive Healthcare make?
Definitive Healthcare reported revenue of $241.52M for fiscal 2025, down 4.24% from fiscal 2024.
Does Definitive Healthcare pay a dividend?
Definitive Healthcare's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Definitive Healthcare Corp.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures